(Q34484974)

English

Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients (English)

1 reference

Europe PubMed Central

2 August 2017

1 reference

based on heuristic

inferred from title

metabolic syndrome

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25291992%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Dorota Frydecka

2

object named as

Dorota Frydecka

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25291992%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Lukasz Laczmanski

3

object named as

Łukasz Łaczmański

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25291992%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

5

object named as

Andrzej Kiejna

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25291992%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Ryszard Ślęzak

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25291992%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

8 October 2014

1 reference

Europe PubMed Central

2 August 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25291992%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

70

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25291992%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25291992%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1433-1441

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25291992%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

copyright license

Creative Commons Attribution 4.0 International

8 October 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1007/s00228-014-1762-2

0 references

Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Elevated homocysteine level in first-episode schizophrenia patients--the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

A two fold risk of metabolic syndrome in a sample of patients with schizophrenia: do consanguinity and family history increase risk?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Meta-analyses of blood homocysteine levels for gender and genetic association studies of the MTHFR C677T polymorphism in schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Excess early mortality in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Homocysteine levels in patients with schizophrenia on clozapine monotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

The multidimensional nature of metabolic syndrome in schizophrenia: lessons from studies of one-carbon metabolism and DNA methylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Determination of olanzapine and N-desmethyl-olanzapine in plasma using a reversed-phase HPLC coupled with coulochemical detection: correlation of olanzapine or N-desmethyl-olanzapine concentration with metabolic parameters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

DNA methylation in schizophrenia: progress and challenges of epigenetic studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Epigenetic studies of schizophrenia: progress, predicaments, and promises for the future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Polymorphisms in MTHFR, MS and CBS genes and homocysteine levels in a Pakistani population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Risperidone versus other atypical antipsychotics for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Serum total homocystein, folate and vitamin B12 levels and their correlation with antipsychotic drug doses in adult male patients with chronic schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Plasma homocysteine in schizophrenia: determinants and clinical correlations in Tunisian patients free from antipsychotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Metabolic syndrome associated with schizophrenia and atypical antipsychotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Review of studies of androgen treatment of female-to-male transsexuals: effects and risks of administration of androgens to females

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Folate, homocysteine, and negative symptoms in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Nicotine dependence and the Fagerström Tolerance Questionnaire: a brief review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Homocysteine export from erythrocytes and its implication for plasma sampling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

6 July 2018

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1762-2

21 January 2018

The comparison of glycometabolism parameters and lipid profiles between drug-naïve, first-episode schizophrenia patients and healthy controls

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1762-2

21 January 2018

Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1762-2

21 January 2018

MTHFR and risk of metabolic syndrome in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1762-2

21 January 2018

MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1762-2

21 January 2018

Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1762-2

21 January 2018

Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1762-2

21 January 2018

Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1762-2

21 January 2018

Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1762-2

21 January 2018

Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1762-2

21 January 2018

Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1762-2

21 January 2018

Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1762-2

21 January 2018

Elevated homocysteine levels in young male patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1762-2

21 January 2018

Homocysteine levels in newly admitted schizophrenic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1762-2

21 January 2018

Neuro- and immunomodulatory steroids and other biochemical markers in drug-naive schizophrenia patients and the effect of treatment with atypical antipsychotics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

27 October 2018

A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4226930

27 October 2018

Folate supplementation in schizophrenia: A possible role for MTHFR genotype

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1762-2

21 January 2018

Association ofFTO,LEPRandMTHFRgene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/25291992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/25291992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25291992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated homocysteine level in siblings of patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25291992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homocysteine and cognition in first-episode psychosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25291992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-014-1762-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25291992%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25291992%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25291992%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34484974&oldid=1952053169"